Literature DB >> 14667115

Extracranial carotid artery stenting in surgically high-risk patients using the Carotid Wallstent endoprosthesis: midterm clinical and ultrasound follow-up results.

Geert Maleux1, Pauwel Bernaerts, Vincent Thijs, Johan Vaninbroukx, Kim Daenens, Inge Fourneau, André Nevelsteen.   

Abstract

The purpose of this study was to evaluate the feasibility, safety and midterm outcome of elective implantation of the Carotid Wallstent in patients considered to be at high surgical risk. In a prospective study, 54 carotid artery stenoses in 51 patients were stented over a 24-month period. Three patients underwent bilateral carotid artery stenting. Institutional inclusion criteria for invasive treatment of carotid occlusive disease (carotid endarterectomy or carotid artery stenting) are patients presenting with a 70% or more symptomatic stenosis and those with an 80% or more asymptomatic stenosis having a life-expectancy of more than 1 year. All patients treated by carotid artery stenting were considered at high risk for carotid endarterectomy because of a hostile neck (17 patients--31.5%) or because of severe comorbidities (37 patients--68.5%). No cerebral protection device was used. Of the 54 lesions, 33 (61.1%) were symptomatic and 21 (38.8%) were asymptomatic. Follow-up was performed by physical examination and by duplex ultrasonography at 1 month, 6 months, 1 year and 2 years after the procedure. All 54 lesions could be stented successfully without periprocedural stroke. Advert events during follow-up (mean 13.9 +/- 5.7 months) were non-stroke-related death in 6 patients (11.1%), minor stroke in 4 stented hemispheres (7.4%), transient ipsilateral facial pain in 1 patient (1.8%), infection of the stented surgical patch in 1 patient (1.8%) and asymptomatic instent restenosis in 4 patients (7.4%). The percutaneous implantation of the Carotid Wallstent, even without cerebral protection device, appears to be a safe procedure with acceptable clinical and ultrasonographic follow-up results in patients at high surgical risk. But some late adverse events such as ipsilateral recurrence of non-disabling (minor) stroke or instent restenosis still remain real challenging problems.

Entities:  

Mesh:

Year:  2003        PMID: 14667115     DOI: 10.1007/s00270-003-0039-4

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  6 in total

1.  Cerebral ischemia after filter-protected carotid artery stenting is common and cannot be predicted by the presence of substantial amount of debris captured by the filter device.

Authors:  G Maleux; P Demaerel; E Verbeken; K Daenens; S Heye; F Van Sonhoven; A Nevelsteen; G Wilms
Journal:  AJNR Am J Neuroradiol       Date:  2006-10       Impact factor: 3.825

2.  Factors affecting long-term restenosis after carotid stenting for carotid atherosclerotic disease.

Authors:  Jai Jai Shiva Shankar; Jingwen Zhang; Marlise dos Santos; Howard Lesiuk; Ravi Mohan; Cheemun Lum
Journal:  Neuroradiology       Date:  2012-04-21       Impact factor: 2.804

3.  Carotid intervention 2: technical considerations.

Authors:  Geert Maleux; Sam Heye
Journal:  Semin Intervent Radiol       Date:  2007-06       Impact factor: 1.513

4.  Multicenter evaluation of a self-expanding carotid stent system with distal protection in the treatment of carotid stenosis.

Authors:  M D Hill; W Morrish; G Soulez; A Nevelsteen; G Maleux; C Rogers; K E Hauptmann; A Bonafé; R Beyar; L Gruberg; J Schofer
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

5.  Comparison of Restenosis Risk in Single-Layer versus Dual-Layer Carotid Stents: A Duplex Ultrasound Evaluation.

Authors:  Ján Sýkora; Kamil Zeleňák; Martin Vorčák; Martin Števík; Martina Sýkorová; Jozef Sivák; Marek Rovňák; Jana Zapletalová; Juraj Mužík; Igor Šinák; Egon Kurča; Lukas Meyer; Jens Fiehler
Journal:  Cardiovasc Intervent Radiol       Date:  2022-07-07       Impact factor: 2.797

6.  Carotid endarterectomy at the millennium: what interventional therapy must match.

Authors:  Glenn M LaMuraglia; David C Brewster; Ashby C Moncure; David J Dorer; Michael C Stoner; Samir K Trehan; Elizabeth C Drummond; William M Abbott; Richard P Cambria
Journal:  Ann Surg       Date:  2004-09       Impact factor: 12.969

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.